Allergen-specific immunoglobulin (null)

“Allergen-specific immunoglobulins” refers collectively to antibodies (usually IgE, but also IgG and IgA) that bind specifically to allergenic antigens. The most clinically important of these is allergen-specific IgE, which is central to allergic diseases and is a biomarker for allergic sensitization. Allergen-specific IgE binds to high- and low-affinity receptors on effector cells (mast cells, basophils) and antigen-presenting cells, leading to cell activation and release of inflammatory mediators upon allergen exposure, resulting in immediate hypersensitivity reactions[1][2][4][5][6]. Allergen-specific IgG (especially IgG4) and IgA can either block or facilitate allergic inflammation, with induced IgG4 serving as a therapeutic mechanism in allergen immunotherapy by competing with IgE for allergen binding and preventing allergic responses[1][2][6]. This is not a single molecular entity or canonical target, but a functional class describing different immunoglobulin isotypes (IgE, IgG, IgA) with specificity for particular allergens. Individual allergen-specific immunoglobulins (e.g., “Der p 1-specific IgE”) should be considered as measurements or reagents, not as direct drug targets. Clarification: This is not a canonical therapeutic target or molecule, but rather a measurement or property (antibody specificity), and thus “is_target” is set to false; “is_incorrect” is true because the entry is non-specific and refers to a class of antibodies rather than a singular target molecule.

Other names

Allergen-specific antibodyAllergen-specific IgEAllergen-specific IgGAllergen-specific IgA

Inhibition of IgE-receptor interaction, Blocking IgE binding to allergen, Immune complex formation, Modulation of immune cell activation